Approximately 10% of regular cannabis users develop cannabis use disorder (DSM-5 criteria). With increasing potency (THC concentrations reaching 20–30%+ in modern products) and daily use becoming more common, the clinical picture has changed significantly from decades past. No FDA-approved medication exists, making behavioral therapy (CBT, motivational enhancement) the primary treatment.
Why Cannabis Addiction Gets Dismissed
Cannabis occupies a unique cultural position — legal in many US states, widely viewed as harmless, and often contrasted favorably with alcohol and opioids. This perception creates a barrier for people who develop problematic use patterns. They're told it's "not addictive," that they just need "more willpower," or that their problem isn't "real" compared to "hard drugs."
The clinical reality is different. The DSM-5 recognizes cannabis use disorder with the same diagnostic framework applied to all substance use disorders: tolerance, withdrawal, inability to control use, continued use despite consequences, and giving up activities in favor of use. The severity spectrum ranges from mild (2–3 criteria) to severe (6+ criteria), just like any other substance.
Cannabis Withdrawal Is Real
Another common misconception: "cannabis doesn't have withdrawal." It does. The DSM-5 includes cannabis withdrawal syndrome, characterized by irritability, anxiety, insomnia, decreased appetite, restlessness, depression, and physical symptoms (abdominal pain, sweating, shakiness). Symptoms typically peak 2–6 days after cessation and can last 1–3 weeks. While not medically dangerous (unlike alcohol or benzodiazepine withdrawal), cannabis withdrawal is uncomfortable enough to drive continued use.
Treatment Approaches
- Cognitive Behavioral Therapy (CBT): Identifying triggers and developing alternative coping strategies — the most-studied and effective behavioral treatment for cannabis use disorder
- Motivational Enhancement Therapy (MET): Resolving ambivalence about change and building internal motivation — particularly effective for cannabis users who aren't fully committed to stopping
- Contingency Management: Tangible incentives for negative drug tests — high effect size in research but underused in clinical practice
- N-Acetylcysteine (NAC): An over-the-counter supplement showing promise in clinical trials for reducing cannabis use, particularly in adolescents and young adults (Level 2 evidence)
When Residential Treatment Makes Sense
Most cannabis use disorder can be treated in outpatient settings. Residential treatment is appropriate when cannabis use is co-occurring with other substance use disorders, the person has failed multiple outpatient attempts, co-occurring mental health conditions require intensive stabilization, or the home environment is a significant trigger for use.
Your Struggle Is Valid
If cannabis is controlling your life, you deserve help — regardless of what anyone says about it "not being a real addiction." Confidential conversations available.
Reach Out Confidentially